Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome

被引:46
|
作者
Alvarez-Rodriguez, Lorena [1 ]
Martinez-Taboada, Victor [2 ]
Calvo-Alen, Jaime [3 ]
Beares, Inaki [1 ]
Villa, Ignacio [4 ]
Lopez-Hoyos, Marcos [5 ]
机构
[1] Univ Hosp Marques de Valdecilla IDIVAL, Rheumatol Dept, Transplantat & Autoimmun Lab, Santander, Spain
[2] Cantabria Univ, Univ Hosp Marques de Valdecilla IDIVAL, Rheumatol Dept, Fac Med, Santander, Spain
[3] Univ Hosp Araba, Rheumatol Dept, Vitoria, Spain
[4] Hosp Sierrallana, Rheumatol Dept, Torrelavega, Spain
[5] Cantabria Univ, Univ Hosp Marques de Valdecilla IDIVAL, Immunol Dept, Santander, Spain
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词
pAPS; SLE; Th1; Th17; Treg; inflammation; REGULATORY T-CELLS; CLASSIFICATION CRITERIA; PATHOGENESIS; ATHEROSCLEROSIS; EXPRESSION; RESPONSES; IMMUNITY; DISEASE;
D O I
10.3389/fimmu.2019.00391
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS) remains elusive. It is possible that differences in the frequencies of Th17 cells and/or defects in the immunoregulatory mechanisms are involved in the pathogenesis of APS. Our aim was to determine the peripheral blood Th cells phenotype and the circulating cytokine profile in patients with primary APS (pAPS) and compare it with systemic lupus erythemathosus (SLE) as disease control group. Methods: The frequencies of circulating regulatory T cells (Tregs) were determined in PBMCs from 36 patients with pAPS by flow cytometry. As control groups we included 21 age-and gender-matched healthy controls (HC) and 11 patients with SLE. The suppressive capacity of Tregs was evaluated in vitro by coculture assay. On the other hand, intracellular cytokine production was assessed in Th1, Th2, and Th17 cells and circulating IL-6, IL-10, and IL-35 were measured by Cytometric Bead Array and ELISA. The quantification of Th master gene expression levels was performed by real time quantitative PCR. Results: pAPS patients and SLE patients did not show differences in the percentage or number of Tregs compared to HC. The suppressive capacity of Tregs was also similar in the three study group. Instead, we found higher FoxP3.mRNA expression levels in pAPS patients and HC than SLE patients. Regarding the Th17 response, patients with pAPS and HC showed a significantly lower frequency of circulating Th17 cells than SLE. However, no differences were observed in the Th1 response between patients and controls. Thus, increased Th17/Th1 and Th17/Treg ratios were found in SLE patients but not in pAPS patients. pAPS and SLE patients had higher serum IL-6 levels than HC but there was not difference between both disease groups. Besides, a significant increase in the immunosuppressive cytokine levels was observed only in pAPS as compared to HC. Conclusions: Our data demonstrate an increased inflammatory profile of peripheral blood CD4(+) T cells from SLE as compared with pAPS mostly due to an increased Th17 response. In conclusion, there seems not to be a direct pathogenic role for Th cells in pAPS but in SLE.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with Systemic Lupus Erythematosus (SLE)
    Zhu Mengya
    Mo Hanyou
    Li Dong
    Luo Xiaohong
    Zhang Lihua
    CLINICAL RHEUMATOLOGY, 2013, 32 (07) : 1045 - 1052
  • [22] Hyperhomocysteinemia in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and antiphospholipid syndrome associated with lupus.
    Prieto, MP
    Muñoz, G
    Hernández, B
    López, LA
    Vargas, A
    González, EH
    Valdéz, MR
    Amigo, MC
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 422 - 422
  • [23] PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS
    MUJIC, F
    CUADRADO, MJ
    LLOYD, M
    KHAMASHTA, MA
    PAGE, G
    HUGHES, GRV
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (08) : 1589 - 1592
  • [24] Th17 cells in rheumatoid arthritis and systemic lupus erythematosus
    Pernis, A. B.
    JOURNAL OF INTERNAL MEDICINE, 2009, 265 (06) : 644 - 652
  • [25] Th17 associated proteins in Juvenile systemic lupus erythematosus
    Ballantine, L.
    Midgley, A.
    Watson, L.
    Beresford, M.
    IMMUNOLOGY, 2011, 135 : 147 - 147
  • [26] SYSTEMIC LUPUS ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME
    Derksen, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 23 - 24
  • [27] Antiphospholipid syndrome in systemic lupus erythematosus
    Hill, Gary S.
    Nochy, Dominique
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (09): : 2461 - 2464
  • [28] Antiphospholipid syndrome in systemic lupus erythematosus
    Rozman, B
    Sipiek-Dolnicar, A
    Ambrozic, A
    Bozic, B
    Vizjak, A
    Ferluga, D
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 273 - 274
  • [29] Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Schroeder, J. O.
    Zeuner, R. A.
    Specker, C.
    AKTUELLE RHEUMATOLOGIE, 2010, 35 (01) : 24 - U1
  • [30] Systemic lupus erythematosus and antiphospholipid syndrome
    Grone, HJ
    PATHOLOGE, 1996, 17 (06): : 405 - 416